boonhup
2022-05-07
Please like and comments thanks 😊
US IPO Weekly Recap: Bausch + Lomb Deal Headlines a 3 IPO Week
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":616437263,"tweetId":"616437263","gmtCreate":1651885860052,"gmtModify":1651885862729,"author":{"id":3570863489388697,"idStr":"3570863489388697","authorId":3570863489388697,"authorIdStr":"3570863489388697","name":"boonhup","avatar":"https://static.tigerbbs.com/aefb0b8716445957d6db1796c7bc4dd4","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":58,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Please like and comments thanks 😊</p></body></html>","htmlText":"<html><head></head><body><p>Please like and comments thanks 😊</p></body></html>","text":"Please like and comments thanks 😊","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/616437263","repostId":1166107339,"repostType":4,"repost":{"id":"1166107339","pubTimestamp":1651885384,"share":"https://www.laohu8.com/m/news/1166107339?lang=&edition=full","pubTime":"2022-05-07 09:03","market":"us","language":"en","title":"US IPO Weekly Recap: Bausch + Lomb Deal Headlines a 3 IPO Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1166107339","media":"Renaissance Capital","summary":"The IPO market showed signs of life after a fairly quiet April, with three IPOs and two SPACs this p","content":"<html><head></head><body><p>The IPO market showed signs of life after a fairly quiet April, with three IPOs and two SPACs this past week. While there were only two new IPO filings, a few large deals in the pipeline updated their prospectuses, including <b>Corebridge Financial</b>(CRBG) and <b>Savers Value Village</b>(SVV).</p><p>In the year’s second largest IPO yet, <b>Bausch + Lomb</b>(BLCO) priced well below the range to raise $630 million at $6.5 billion market cap in its return to public markets, finishing up 11%. The offering was 100% secondary, and the company dual listed on the NYSE and the TSX. Highly profitable with strong cash flow, Bausch + Lomb offers a broad portfolio of well-known brands with leading market positions, though margins have declined over the last several years.</p><p>Neuromuscular disease biotech <b>PepGen</b>(PEPG) added more shares but priced below the range, raising $108 million at a $277 million market cap. PepGen’s lead candidate is being developed for muscular dystrophy and is currently in a Phase 1 trial, with topline data expected by the end of this year. PepGen finished up 7%.</p><p>Canadian gold exploration company <b>Austin Gold</b>(AUST) raised $13 million at a $52 million market cap. The company has interests in four properties, one of which they consider material. While not counted below, agriculture nano-cap <b>Edible Garden</b>(EDBL) raised $15 million, offering units.</p><p>Two SPACs came to market: <b>Cartesian Growth II</b>(RENEU), which raised $200 million to target high-growth businesses, and <b>A SPAC II Acquisition</b>(ASCBU), which raised $185 million to target new economy sectors in North America, Europe, and Asia.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: Bausch + Lomb Deal Headlines a 3 IPO Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: Bausch + Lomb Deal Headlines a 3 IPO Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-07 09:03 GMT+8 <a href=https://www.renaissancecapital.com/IPO-Center/News/92501/US-IPO-Weekly-Recap-Bausch-+-Lomb-deal-headlines-a-3-IPO-week><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market showed signs of life after a fairly quiet April, with three IPOs and two SPACs this past week. While there were only two new IPO filings, a few large deals in the pipeline updated their...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/92501/US-IPO-Weekly-Recap-Bausch-+-Lomb-deal-headlines-a-3-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/92501/US-IPO-Weekly-Recap-Bausch-+-Lomb-deal-headlines-a-3-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166107339","content_text":"The IPO market showed signs of life after a fairly quiet April, with three IPOs and two SPACs this past week. While there were only two new IPO filings, a few large deals in the pipeline updated their prospectuses, including Corebridge Financial(CRBG) and Savers Value Village(SVV).In the year’s second largest IPO yet, Bausch + Lomb(BLCO) priced well below the range to raise $630 million at $6.5 billion market cap in its return to public markets, finishing up 11%. The offering was 100% secondary, and the company dual listed on the NYSE and the TSX. Highly profitable with strong cash flow, Bausch + Lomb offers a broad portfolio of well-known brands with leading market positions, though margins have declined over the last several years.Neuromuscular disease biotech PepGen(PEPG) added more shares but priced below the range, raising $108 million at a $277 million market cap. PepGen’s lead candidate is being developed for muscular dystrophy and is currently in a Phase 1 trial, with topline data expected by the end of this year. PepGen finished up 7%.Canadian gold exploration company Austin Gold(AUST) raised $13 million at a $52 million market cap. The company has interests in four properties, one of which they consider material. While not counted below, agriculture nano-cap Edible Garden(EDBL) raised $15 million, offering units.Two SPACs came to market: Cartesian Growth II(RENEU), which raised $200 million to target high-growth businesses, and A SPAC II Acquisition(ASCBU), which raised $185 million to target new economy sectors in North America, Europe, and Asia.","news_type":1},"isVote":1,"tweetType":1,"viewCount":789,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":29,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/616437263"}
精彩评论